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Abstract 
Salmonellosis is an important public health concern among children in worldwide. Extended-spectrum 
β-lactams (ESBLs) cause resistance to clinically important beta-lactams which are generally used to 
treat invasive Salmonella infections. Therefore, the aim of this study was to investigate the presence of 
SHV, TEM and CTX-M genes in different strains of Salmonella isolated from children with acute 
diarrhea and to determine their resistance profile. In this cross-sectional study, 300 fecal samples were 
collected from children referred to the Amirkola Children's Hospital, Babol, Iran. Antibiotic 
susceptibility testing was done according to the CLSI guideline. ESBLs-producing strains were 
identified using double disk synergy test method on the Mueller-Hinton agar plates. Multiplex-PCR 
was performed using oligonucleotide specific primers to detect of SHV, TEM and CTX-M genes. In total, 
7% (n; 21/300) salmonella were isolated, which 61.9%, 28.6% and 9.5% were Salmonella typhimurium, 
Salmonella enteritidis and Salmonella typhi, respectively. The prevalence of the ESBL-producing 
isolates were 52.4%. M-PCR results showed that 42.8%, 38.1% and 14.3% of isolates were carried CTX-
M, TEM and SHV genes, respectively. Also, 18.2% of isolates harbored CTX-M, and TEM genes, 
simultaneously. The high rate of ESBLs-producing Salmonella strains in the pediatric patients is an 
alarm. It is also recommended that alternative drugs be used with less resistance, which requires further 
investigation. 
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1. Introduction 
Salmonella, a member of the Enterobacteriaceae 
family, are Gram-negative bacilli and spore-free that 
most normally transmitted from animals to humans 
[1]. These intestinal organisms, which are often 
considered potential pathogens for humans, have 
more than 2,500 different serovars that are divided 
into three distinct species including, Salmonella typhi, 
Salmonella choleraesuis, and Salmonella enterica [2]. 
Salmonella entrica sub-species entrica serovar 
Enteritidis (briefly S. enteritidis) is the most important 
cause of Non-typhoidal Salmonellosis. This disease is 
one of the most important infectious diseases between 
humans and animals, which is mostly related to the 
consumption of meat, poultry, eggs and milk [3]. So 
this bacterium is a food-borne pathogen. 
Salmonellosis can develop into one of the forms of 
typhoid fever, septicemia, and gastrointestinal 
infections (gastroenteritis). Gastroenteritis is the most 
common form of salmonellosis, often associated with 
symptoms such as fever, abdominal cramps, and 
diarrhea. The most common serotypes involved in this 
form is S. typhimurium and S. enteritis [4]. The course 
of the disease lasts 4 to 7 days and many people recover 
without the need for antibiotics [5]. 
 Today, one of the most important antimicrobials 
used in treatment of Salmonellosis is β-lactam agents. 
Unfortunately, for some reason, the addition of 
antibiotics to the diet of livestock, improper and 
arbitrary use of antibiotics, and lack of careful 
surveillance of drug administration have led to 
antibiotic-resistant strains [6]. The main problem in 
treating infections caused by these organisms is the 
emergence of multidrug resistance (MDR) strains, 
which often lead to prolonged hospitalization, increase 
mortality and mobility rates and increase the cost of 
treatment [7]. 
 β-lactamases are a class of enzymes that 
hydrolysis the amide bond in the β-lactam ring of 
penicillins and cephalosporins. A common 
classification system is Ambler system which 
categorizes these enzyme into 4 dissimilar groups (A, 
B, C, D), based on the structure. Ambler type A (broad-
spectrum beta-lactamases (ESBL), C 
(Cephalosporinase), and D (oxacillinase) β-
lactamases are categorized as a serine β-lactamases 
because they have ser amino acid at the enzyme's 
active site [8]. Ambler type B enzyme is classified as a 
metalloenzyme since the type need a divalent cations, 
usually zinc in active site to function. The spread of 
ESBLs is a global public health concern. ESBLs can 
develop resistance to antimicrobials such as 3th and 
4th generation cephalosporins and monobactams [9]. 
The most common type of ESBLs in clinical samples is 
SHV, whose coding gene is located on a transferable 
plasmid and is therefore easily distributed among 
bacterial strains [10]. SHV β-lactamases are inhibited 
by clavulanic acid but not by EDTA. The TEM-1 was 
the first broad-spectrum β-lactamase, found not only 
in Enterobacteriaceae but also in Pseudomonas 
aeruginosa [11]. Among ESBLs, the CTX-M group has 
been described globally. The CTX-M gene is located on 
a transferable plasmid and is effective on the 
cefotaxime (a 3th-generation cephalosporin). These 
enzymes have the ability to hydrolyze cephalosporins 
and are inhibited by clavulanic acid, sulbactam, and 
tazobactam. CTX-M types are widely spread around 
the world. Although Salmonella serotypes are a 
significant etiologic agents of diarrhea in various parts 
of the world, very few reports are obtainable about the 
incidence of ESBLs among them [12]. So, the aim of 
the current study is to detect ESBL-encoded genes 
(TEM, SHV and CTX-M) in the Salmonella isolated 
from children with acute diarrhea and determination 
of the resistance pattern of these strains. 
2. Materials and Methods 
2.1. Bacterial isolation 
In this cross-sectional study, which was 
performed over a period of 9 months (from the 
February to October 2019), in total 300 stool samples 
were obtained from the children's suspected to 
Salmonellosis at the Amirkola Children's Hospital, 
Babol, Iran. In laboratory, each sample was enriched 
using culturing on the Selenite-F Broth (Mercury, 
Germany). After incubation on the 37˚C for 24h, 
samples were cultured on the Eosin Methylene Blue 
(EMB) agar and Xylose Lysine Deoxycholate (XLD) 
agar (Merck, Germany) plates. Lactose negative 
colonies were identified by API 20E system 
(BioMerieux, France). All Salmonella spp. Isolates 
were serotyped with Salmonella specific O and H 
antisera using the slide agglutination test. 
2.2. Antimicrobial susceptibility test 
In according to the Standard Institute of 
Laboratory and Clinical Standards (CLSI), 
Antimicrobial susceptibility test was determined using 
agar disk diffusion method on the Mueller-Hinton 
agar (MHA) (Merck Co, Germany) for ceftazidime (30 
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µg), Aztreonam (30 µg), Imipenem (10 µg), 
Cefotaxime (30 µg), Ofloxacin (5 µg), Amikacin (30 
µg) and Tetracycline (30 µg) (HiMedia, India) [13]. 
2.3. Double disk synergy test (DDST) 
DDST was used for ESBL-producing isolates, 
cefotaxime 30 µg and ceftazidime 30 µg with and 
without clavulanic acid 10 µg (Mast, UK). The 0.5 
McFarland standard turbidity of isolates were spread 
on the Muller Hinton agar (Merck, Germany). DDST 
was done by comparing the inhibition zone of disks 
containing cefotaxime and ceftazidime with and 
without clavulanic acid. When zones were distended < 
5 mm around the disk comprising clavulanic acid the 
strain were considered as ESBL positive. Klebsiella 
pneumoniae ATCC 7006039 was used as a positive 
control [14]. 
2.4. Multiplex PCR 
Cellular DNA was extracted by the boiling way 
formerly defined previously [15]. The M-PCR was 
done using specific primers to identify SHV, TEM and 
CTX-M genes (Table 1). The PCR reaction was 
performed at a volume of 25 μl. Each PCR reaction 
includes, 1.5 µL of template DNA, 12.5 µL of CinnaGen 
PCR Master Mix, 1.0 µL of each primer, and 9 µL of 
ddH2O. The M-PCR reaction was performed for 33 
cycles in an Eppendorf MasterCycle Gradient 
thermocycler (Eppendorf, Germany) with the 
fallowing program, initial denaturation at 94°C for 6 
min, denaturation at 95°C for 45 s, annealing at 57°C 
for 60 s, extension at 72°C for 60 s and a final extension 
at 72°C for 7 min. M-PCR amplicons were 
electrophoresed in a 1% agarose/0.5 × TBE (45 mM-
Tris-borate, 1 mM-EDTA) gel stained with 0.1 μl/ml 
Gel Red™ (Biotium, USA), then photographed under 
an UV trans-illuminator. The 100-bp DNA ladder 
(CinnaGen, Iran) was used as a molecular size marker. 
3. Results 
The mean age of the patients was 13.6±1.2 years 
(range from 4 to 14 years), which 45.3% (n; 163) were 
female and 45.6% (n; 137) male. In total, 7% (n; 
21/300) salmonella species were collected, which 
61.9% (n; 13/21), 28.6% (n; 6/21) and 9.5% (n; 2/21) 
were S. typhimurium, S. enteritidis and S. typhi, 
respectively. Antibiotic susceptibility test showed that 
all isolates were susceptible to imipenem (Table 2). 
Moreover, 42.8% (n; 9/21) of isolates were resistant to 
at least 3 different antibiotic classes and therefore 
considered MDR. Most MDR strains belonged to S. 
typhimurium serotype. 
The results of DDST showed that 52.4% (n; 11) of 
isolates had ESBL-positive phenotype. The results of 
M-PCR showed that 42.8% (n; 9), 38.1% (n; 8) and 
14.3% (n; 3) of isolates were carried CTX-M, TEM and 
SHV genes, respectively. Also, 18.2% (n; 2) of isolates 





































































































































































































































































































Diarrheal diseases caused by Salmonella are a 
worldwide health problem. Most people improve 
without specific treatment. Antibiotics are usually 
used only to treat cases suffering from severe infection. 
Patients should drink extra liquids as long as diarrhea 
lasts. In some cases, diarrhea may be so severe that the 
person needs to be hospitalized. Occasionally, 
infection may spread from the intestines to the 
bloodstream, and then to other parts of the body. In 
these cases, Salmonella can cause death unless the 
person is treated promptly with antibiotics. β-
lactamases are extensively used in the treatment of 
salmonellosis [1]. In the present study, out of 300 stool 
samples, 7% Salmonella spp. were obtained, which is 
consistent with the study directed by Nodeh Farahani 
et al. [18]. This contradiction can be related to the 
number of samples and the year of study. In 
agreement with Soltan Dallal et al. [19], slide 
agglutination test results showed that 61.9%, 28.6% 
and 9.5% of isolates were belonged to the S. 
typhimurium, S. enteritidis and S. typhi serotypes, 
respectively. This variation may be resulted from 
distribution of different serotypes in various 
geographical areas. 
Antimicrobial susceptibility test showed that all 
strains were susceptible to the imipenem, which was 
fully consistent with the study of Eshraghi et al. [20]. 
Also, 80.9% of isolates were resistant to tetracycline 
which was consistent with findings of Siourimè et al. 
[21]. In our study, with the exception of only one strain 
(S. enteritidis), all of them (20 isolates; 95.2%) were 
sensitive to ciprofloxacin, which is almost consistent  
 
with the results of Eshraghi et al. [20]. The researchers 
showed that the favorable effect of quinolones in 
combination with cephalosporins. Spiliopoulou et al. 
showed that all isolates were sensitive to ceftriaxone 
and ciprofloxacin, which is consistent with the present 
study [22]. This agreement could be due to the lack of 
need for antibiotics in the treatment of salmonellosis 
and its self-limitation. 
In the DDST test, 52.4% of isolates were ESBLs 
producing phenotype. Also, the prevalence of CTX-M, 
TEM and SHV genes were 42.8%, 38.1%, and 14.3%, 
respectively. These data are inconsistent with the 
study of Tajbakhsh et al., since that all 174 Salmonella 
species were negative for TEM, CTX-M and SHV 
genes [23]. These results could be due to the 
geographical distance and the presence of other 
resistance mechanisms such as, efflux pumps, 
chromosomal beta-lactamase and porin loss. Of 138 S. 
enterica, 29.6% (n; 40) ESBL-producing isolates were 
collected by Ranjbar et al. [24]. The frequency of CTX-
M, TEM and SHV genes was 12.3% (n; 17), 29.9% (n; 
40) and 2.9% (n; 4), respectively, which was different 
with the present study. These results are important as 
an alarming in the development of resistance genes to 
the other susceptible strains and special attention to 
these strains. All 92 Salmonella spp. collected by 
Boisramé-Gastrin et al. were positive for TEM gene. 
So, 22.8% (n; 21/92) and 5.4% (n; 21/92) of isolates 
were harbored SHV and CTX-M genes, respectively 
[25]. The present study provided information on the 
frequency and antimicrobial susceptibility profile of 
Salmonella isolates in Iran. The high rates of ESBLs 
positive-Salmonella strains collected from pediatric 
    Table 2. Antibiotic susceptibility profile 
 
Antimicrobial agents 
S. typhimurium (n=13) S. enteritidis  (n=6) S. typhi (n=2) 
S I R S I R S I R 
Ceftazidime 3 (23.1) 1 (7.7) 9 (69.2) 1 (16.6) 0 5 (83.3) 0 0 2 (100) 
Aztreonam 4 (30.7) 1 (7.7) 8 (61.5) 2 (33.3) 0 4 (66.6) 0 0 2 (100) 
Imipenem 13 (100) 0 0 6 (100) 0 0 2 (100) 0 0 
Cefotaxime 4 (30.7) 0 9 (69.2) 2 (33.3) 0 4 (66.6) 0 0 2 (100) 
Ofloxacin 8 (61.5) 1 (7.7) 4 (30.7) 4 (66.6) 1 (16.6) 1 (16.6) 1 (50) 1 (50) 0 
Amikacin 2 (15.4) 2 (15.4) 9 (69.2) 5 (83.3) 0 1 (16.6) 0 0 2 (100) 
Tetracycline 3 (23.1) 0 10 (76.9) 1 (16.6) 0 5 (83.3) 0 0 2 (100) 
Ceftriaxone 12 (92.3) 0 1 (7.7) 5 (83.3) 0 1 (16.6) 2 (100) 0 0 
Ciprofloxacin 12 (92.3) 0 1 (7.7) 6 (100) 0 0 2 (100) 0 0 
 
    Results presented as No. (%) 
    Abbreviations: S; susceptible; I: intermediate-resistant; R: resistant 
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cases is alarming and indicates a necessity to substitute 
the cephalosporins with an appropriate alternative. 
Current limitations include the limited number of 
serotypes identified and resistance genes. It is also 
suggested that other resistance genes and other types 
of beta-lactamases should be identified. 
Accurate diagnosis and rapid identification of 
ESBLs-producing Salmonella strains from pediatric 
patients is very important. Therefore, continuous 
monitoring of these resistances, especially at the 
endemic region, is an obvious thing that can prevent 
the spread of resistance to other strains and reduce the 
cost of treatment. 
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